We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-2.83%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$192M
AUM Growth
+$3.31M
Cap. Flow
+$10.5M
Cap. Flow %
5.46%
Top 10 Hldgs %
24.46%
Holding
454
New
344
Increased
40
Reduced
39
Closed
4

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2M
2
GS icon
Goldman Sachs
GS
+$1.47M
3
GSK icon
GSK
GSK
+$1.35M
4
JNJ icon
Johnson & Johnson
JNJ
+$608K
5
TOTL icon
State Street DoubleLine Total Return Tactical ETF
TOTL
+$360K

Top Sells

Rank Stock Value
1
LNCE
Snyders-Lance, Inc.
LNCE
+$3.92M
2
BF.B icon
Brown-Forman Class B
BF.B
+$2.98M
3
WBA
Walgreens Boots Alliance
WBA
+$1.52M
4
GIS icon
General Mills
GIS
+$227K
5
YUM icon
Yum! Brands
YUM
+$225K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.13%
2 Healthcare 17.42%
3 Financials 15.91%
4 Communication Services 8.72%
5 Industrials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOTZ icon
401
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.46B
$2K ﹤0.01%
+100
New +$2.52K
CCJ icon
402
Cameco
CCJ
$40.5B
$2K ﹤0.01%
+200
New +$1.85K
CERS icon
403
Cerus
CERS
$433M
$2K ﹤0.01%
+300
New +$1.36K
CTSO icon
404
Cytosorbents Corp
CTSO
$23.1M
$2K ﹤0.01%
+250
New +$1.89K
FIZZ icon
405
National Beverage
FIZZ
$2.97B
$2K ﹤0.01%
+48
New +$2.36K
HDV
406
iShares Core High Dividend ETF
HDV
$14.8B
$2K ﹤0.01%
+100
New +$1.76K
IHI icon
407
iShares US Medical Devices ETF
IHI
$3.36B
$2K ﹤0.01%
+54
New +$1.66K
PJT icon
408
PJT Partners
PJT
$4.36B
$2K ﹤0.01%
+40
New +$1.93K
QSR icon
409
Restaurant Brands International
QSR
$25.3B
$2K ﹤0.01%
+28
New +$1.66K
SCHB icon
410
Schwab US Broad Market ETF
SCHB
$44.7B
$2K ﹤0.01%
+210
New +$2.31K
SCHO icon
411
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$2K ﹤0.01%
+100
New +$2.49K
SU icon
412
Suncor Energy
SU
$76.1B
$2K ﹤0.01%
+55
New +$1.92K
UA icon
413
Under Armour Class C
UA
$2.86B
$2K ﹤0.01%
+151
New +$2.13K
EQM
414
DELISTED
EQM Midstream Partners, LP
EQM
$2K ﹤0.01%
+40
New +$2.71K
APPS icon
415
Digital Turbine
APPS
$1.15B
$1K ﹤0.01%
+500
New +$1.09K
ASM
416
Avino Silver & Gold Mines
ASM
$1.04B
$1K ﹤0.01%
+476
New +$654
ASYS icon
417
Amtech Systems
ASYS
$275M
$1K ﹤0.01%
+200
New +$1.8K
AVNS
418
DELISTED
Avanos Medical
AVNS
$1K ﹤0.01%
+18
New +$855
CLIR icon
419
ClearSign Technologies
CLIR
$25M
$1K ﹤0.01%
+30
New +$732
DAL icon
420
Delta Air Lines
DAL
$61B
$1K ﹤0.01%
+24
New +$1.32K
FHN icon
421
First Horizon
FHN
$12.2B
$1K ﹤0.01%
+44
New +$867
FURY
422
Fury Gold Mines
FURY
$105M
$1K ﹤0.01%
+175
New +$566
IJJ icon
423
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
$1K ﹤0.01%
+12
New +$952
IJK icon
424
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.1B
$1K ﹤0.01%
+24
New +$1.33K
IJT icon
425
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.52B
$1K ﹤0.01%
+14
New +$1.22K
15 16
17
18 19

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
DWA
Dorsey Wright & Associates Pasadena, California $807M AUM 65.46% 1-Year Est. Return

Kavar Capital Partners Group's Q1 2018 Portfolio in Review

As of Q1 2018, Kavar Capital Partners Group held 454 positions worth $192M, up 1.8% from $188M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Kavar Capital Partners Group deployed $10.5M of net new capital in Q1 2018, opening 344 new positions and adding to 40 existing holdings. Its largest new stake was Gilead Sciences: 25,100 shares worth $1.89M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $1.52M trimmed.

  • Kavar Capital Partners Group's largest Q1 2018 buy was Gilead Sciences: 25,100 shares worth $1.89M.
  • Kavar Capital Partners Group added most to GSK in Q1 2018, an estimated $1.35M increase.
  • Kavar Capital Partners Group's biggest Q1 2018 reduction was Walgreens Boots Alliance, cutting an estimated $1.52M.
  • Kavar Capital Partners Group fully exited Snyders-Lance, Inc. in Q1 2018, selling an estimated $3.92M.
  • Kavar Capital Partners Group's ten largest holdings make up 24% of its $192M portfolio in Q1 2018.
  • Kavar Capital Partners Group opened 344 new positions and closed 4 in Q1 2018.
  • Kavar Capital Partners Group's portfolio value rose 1.8% quarter-over-quarter to $192M.

Based on Kavar Capital Partners Group's 13F filing for Q1 2018, filed 16 May 2019.